Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024.
- Revenue
- +26.1%
- EPS
- −16.7%
- Free cash flow
- +158.7%
- Total debt
- −0.82%
Quarter to September 2026, against a year earlier
Follow HUM
Alert me
Humana Inc. (HUM) Operating cash flow
Humana Inc.'s operating cash flow for fiscal 2025 was $921.0M, down 68.9% from $3.0B in fiscal 2024. Over the twelve months to 30 September 2026 it was $3.7B. Over the past ten years it has ranged from $868.0M (fiscal 2015) to $5.6B (fiscal 2020); the current reading is higher than 18% of that period. Operating cash flow has fallen for 3 consecutive fiscal years. Humana Inc. ranks 7th of 12 Healthcare Plans companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $921.0M | (68.95%) |
| FY2024 | $3.0B | (25.50%) |
| FY2023 | $4.0B | (13.21%) |
| FY2022 | $4.6B | 102.79% |
| FY2021 | $2.3B | (59.89%) |
| FY2020 | $5.6B | 6.72% |
| FY2019 | $5.3B | 143.17% |
| FY2018 | $2.2B | (46.36%) |
| FY2017 | $4.1B | 109.25% |
| FY2016 | $1.9B | 123.04% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $2.2B | 10.02% |
| Jun 2026 | $2.0B | 56.78% |
| Mar 2026 | $1.3B | — |
| Dec 2025 | −$1.7B | — |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $26.2B |
| CVS CVS Health Corporation compare | $18.7B |
| CI Cigna Group compare | $9.4B |
| ELV Elevance Health, Inc. compare | $7.6B |
| CNC Centene Corporation compare | $4.7B |
| OSCR Oscar Health, Inc. compare | $4.2B |
| HUM Humana Inc. | $3.7B |
| MOH Molina Healthcare, Inc compare | $331.0M |
| PGNY Progyny, Inc. compare | $207.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on HUM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement